P. Donga

发表

Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US

C. Pashos, Bin Zhang, M. Corral, 2011, PharmacoEconomics.

Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States

P. Lefebvre, M. Lafeuille, C. Rossi, 2022, Journal of health economics and outcomes research.

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Patient preference and adherence.

Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study

S. Suner, G. Ispas, Y. Vandendijck, 2022, Influenza and other respiratory viruses.

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy

G. McComsey, B. Bookhart, M. Lafeuille, 2022, Infectious Diseases and Therapy.

Adherence and Persistence Patterns in Medication Use Among Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

R. Wade, M. Marcus, C. Donatucci, 2017, American journal of men's health.

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy

G. McComsey, B. Bookhart, M. Lafeuille, 2022, Infectious Diseases and Therapy.

Wait and watch approach in managing acute otitis media: current awareness, attitude and their relationship with the behaviour among primary care physicians

S. Sansgiry, Elizabeth A. Coyle, R. Yeh, 2011 .

Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors

C. Pericone, Yen-Wen Chen, P. Donga, 2022, Journal of health economics and outcomes research.

Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany

T. Fan, Jerrold W. Hill, S. Kachroo, 2015, Rheumatology International.

Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews

B. Taiwo, M. Lafeuille, P. Donga, 2022, Journal of drug assessment.

Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura

S. P. Bilir, J. Munakata, T. Babinchak, 2017, Journal of medical economics.

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States

G. McComsey, Jay Lin, R. Rogers, 2021, Advances in Therapy.

Economic Burden of HIV in a Commercially Insured Population in the United States

B. Taiwo, P. Donga, Cindy Chen, 2023, Journal of health economics and outcomes research.

Comparative healthcare costs in patients with metastatic melanoma in the USA

V. Schabert, J. Munakata, C. Reyes, 2015, Melanoma research.

Improving healthcare efficiency.

M. DeKoven, V. Divino, P. Donga, 2012, Journal of comparative effectiveness research.

Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States

P. Lefebvre, B. Bookhart, M. Lafeuille, 2021, Current medical research and opinion.

Survival of U.S. Medicare patients with advanced non-small cell lung cancer by line of therapy.

C. Blanchette, M. Salvati, J. Penrod, 2014 .

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study

P. Lefebvre, M. Lafeuille, Aurélie Côté-Sergent, 2021, Journal of health economics and outcomes research.

An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Current medical research and opinion.

Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States

P. Rebeiro, B. Bookhart, M. Lafeuille, 2023, Journal of the International AIDS Society.

Experiences and treatment patterns of hypogonadal men in a U.S. health system

C. Burudpakdee, P. Polzer, P. Donga, 2014, International journal of clinical practice.

Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors

B. Bookhart, M. Lafeuille, C. Rossi, 2022, Journal of comparative effectiveness research.

AB1077 Treatment Patterns and Persistence with Subcutaneous Biologic Therapies in Patients with Ankylosing Spondylitis

J. Korn, T. Fan, Q. Ding, 2014 .

Health State Utilities Among Metastatic Castrate-Resistant Prostate Cancer Patients With and Without Symptomatic Skeletal Events

J. Munakata, A. Valderrama, P. Donga, 2014 .

Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan

P. Polzer, P. Donga, R. Wade, 2015, International journal of clinical practice.

Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1

B. Bookhart, M. Lafeuille, C. Rossi, 2023, ClinicoEconomics and outcomes research : CEOR.

Comparative health care (HC) costs in patients (pts) with metastatic melanoma (mM).

V. Schabert, J. Munakata, C. Reyes, 2014 .